Shiga toxin 1-induced inflammatory response in lipopolysaccharide- sensitized astrocytes is mediated by endogenous tumor necrosis factor alpha

Infection and Immunity

Volumn 78, Issue 3, 2010, Pages 1193-1201

  Landoni, Verónica I ^a,b   De Campos Nebel, Marcelo ^a   Schierloh, Pablo ^a   Calatayud, Cecilia ^c   Fernandez, Gabriela C ^a,b   Ramos, M Victoria ^a,b   Rearte, Bárbara ^a,b   Palermo, Marina S ^a,b   Isturiz, Martín A ^a,b  

^a ACADEMIA NACIONAL DE MEDICINA   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA; VEROTOXIN 1;

ANIMAL CELL; ARTICLE; ASTROCYTE; CONTROLLED STUDY; ENCEPHALITIS; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ASTROCYTES; CELLS, CULTURED; ESCHERICHIA COLI; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; NITRIC OXIDE; RATS; SHIGA TOXIN 1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77349097325     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00932-09     Document Type: Article

References (48)

1. Abbott, N. J. 2000. Inflammatory mediators and modulation of blood-brain barrier permeability. Cell. Mol. Neurobiol. 20:131-147.
2. Arthur, F. E., R. R. Shivers, and P. D. Bowman. 1987. Astrocyte-mediated induction of tight junctions in brain capillary endothelium: an efficient in vitro model. Brain Res. 433:155-159.
3. Barone, F. C., L. M. Hillegass, W. J. Price, R. F. White, E. V. Lee, G. Z. Feuerstein, H. M. Sarau, R. K. Clark, and D. E. Griswold. 1991. Polymorphonuclear leukocyte infiltration into cerebral focal ischemic tissue: myeloperoxidase activity assay and histologic verification. J. Neurosci. Res. 29:336-345.
4. Beck, D. W., H. V. Vinters, M. N. Hart, and P. A. Cancilla. 1984. Glial cells influence polarity of the blood-brain barrier. J. Neuropathol. Exp. Neurol. 43:219-224.
5. Betsuyaku, T., F. Liu, R. M. Senior, J. S. Haug, E. J. Brown, S. L. Jones, K. Matsushima, and D. C. Link. 1999. A functional granulocyte colony-stimulating factor receptor is required for normal chemoattractant- induced neutrophil activation. J. Clin. Invest. 103:825-832.
6. Blanc, E. M., A. J. Bruce-Keller, and M. P. Mattson. 1998. Astrocytic gap junctional communication decreases neuronal vulnerability to oxidative stress-induced disruption of Ca2+ homeostasis and cell death. J. Neurochem. 70:958-970.
7. Boccoli, J., C. F. Loidl, J. J. Lopez-Costa, V. P. Creydt, C. Ibarra, and J. Goldstein. 2008. Intracerebroventricular administration of Shiga toxin type 2 altered the expression levels of neuronal nitric oxide synthase and glial fibrillary acidic protein in rat brains. Brain Res. 1230:320-333.
8. Brambilla, R., T. Persaud, X. Hu, S. Karmally, V. I. Shestopalov, G. Dvoriantchikova, D. Ivanov, L. Nathanson, S. R. Barnum, and J. R. Bethea. 2009. Transgenic inhibition of astroglial NF-kappa B improves functional outcome in experimental autoimmune encephalomyelitis by suppressing chronic central nervous system inflammation. J. Immunol. 182:2628-2640.
9. Chen, Y., R. M. McCarron, N. Azzam, J. Bembry, C. Reutzler, F. A. Lenz, and M. Spatz. 2000. Endothelin-1 and nitric oxide affect human cerebromicrovascular endothelial responses and signal transduction. Acta Neurochir. Suppl. 76:131-135.
10. Connolly, E. S., Jr., C. J. Winfree, T. A. Springer, Y. Naka, H. Liao, S. D. Yan, D. M. Stern, R. A. Solomon, J. C. Gutierrez-Ramos, and D. J. Pinsky. 1996. Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion. Role of neutrophil adhesion in the pathogenesis of stroke. J. Clin. Invest. 97:209-216.
11. Eisenhauer, P. B., P. Chaturvedi, R. E. Fine, A. J. Ritchie, J. S. Pober, T. G. Cleary, and D. S. Newburg. 2001. Tumor necrosis factor alpha increases human cerebral endothelial cell Gb3 and sensitivity to Shiga toxin. Infect. Immun. 69:1889-1894.
12. Endo, Y., K. Tsurugi, T. Yutsudo, Y. Takeda, T. Ogasawara, and K. Igarashi. 1988. Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. Eur. J. Biochem. 171:45-50.
13. Eng, L. F., and R. S. Ghirnikar. 1994. GFAP and astrogliosis. Brain Pathol. 4:229-237.
14. Eriksson, K. J., S. G. Boyd, and R. C. Tasker. 2001. Acute neurology and neurophysiology of haemolytic-uraemic syndrome. Arch. Dis. Child. 84:434-435.
15. Exeni, R. A., G. C. Fernandez, and M. S. Palermo. 2007. Role of polymorphonuclear leukocytes in the pathophysiology of typical hemolytic uremic syndrome. ScientificWorldJournal 7:1155-1164.
16. Fan, L., P. R. Young, F. C. Barone, G. Z. Feuerstein, D. H. Smith, and T. K. McIntosh. 1996. Experimental brain injury induces differential expression of tumor necrosis factor-alpha mRNA in the CNS. Brain Res. Mol. Brain Res. 36:287-291.
17. Fernandez, G. C., S. A. Gomez, M. V. Ramos, L. Bentancor, R. J. Fernandez-Brando, V. I. Landoni, L. Lopez, F. Ramirez, M. Diaz, M. Alduncin, I. Grimoldi, R. Exeni, M. A. Isturiz, and M. S. Palermo. 2007. The functional state of neutrophils correlates with the severity of renal dysfunction in children with hemolytic uremic syndrome. Pediatr. Res. 61:123-128.
18. Fernandez, G. C., S. A. Gomez, C. J. Rubel, L. V. Bentancor, P. Barrionuevo, M. Alduncin, I. Grimoldi, R. Exeni, M. A. Isturiz, and M. S. Palermo. 2005. Impaired neutrophils in children with the typical form of hemolytic uremic syndrome. Pediatr. Nephrol. 20:1306-1314.
19. Fujii, J., Y. Kinoshita, Y. Yamada, T. Yutsudo, T. Kita, T. Takeda, and S. Yoshida. 1998. Neurotoxicity of intrathecal Shiga toxin 2 and protection by intrathecal injection of anti-Shiga toxin 2 antiserum in rabbits. Microb. Pathog. 25:139-146.
20. Fujii, J., T. Kita, S. Yoshida, T. Takeda, H. Kobayashi, N. Tanaka, K. Ohsato, and Y. Mizuguchi. 1994. Direct evidence of neuron impairment by oral infection with verotoxin-producing Escherichia coli O157:H- in mitomycin-treated mice. Infect. Immun. 62:3447-3453.
21. Fukuda, M., K. Kitaichi, F. Abe, Y. Fujimoto, K. Takagi, T. Morishima, and T. Hasegawa. 2005. Altered brain penetration of diclofenac and mefenamic acid, but not acetaminophen, in Shiga-like toxin II-treated mice. J. Pharmacol. Sci. 97:525-532.
22. Geelen, J. M., T. J. van der Velden, D. M. Te Loo, O. C. Boerman, L. P. van den Heuvel, and L. A. Monnens. 2007. Lack of specific binding of Shiga-like toxin (verocytotoxin) and non-specific interaction of Shiga-like toxin 2 antibody with human polymorphonuclear leucocytes. Nephrol. Dial. Transplant. 22:749-755.
23. Goldstein, J., C. F. Loidl, V. P. Creydt, J. Boccoli, and C. Ibarra. 2007. Intracerebroventricular administration of Shiga toxin type 2 induces striatal neuronal death and glial alterations: an ultrastructural study. Brain Res. 1161:106-115.
24. Kacem, K., P. Lacombe, J. Seylaz, and G. Bonvento. 1998. Structural organization of the perivascular astrocyte endfeet and their relationship with the endothelial glucose transporter: a confocal microscopy study. Glia 23:1-10.
25. Lin, S. T., Y. Wang, Y. Xue, D. C. Feng, Y. Xu, and L. Y. Xu. 2008. Tetrandrine suppresses LPS-induced astrocyte activation via modulating IKKs-IkappaBalpha-NF-kappaB signaling pathway. Mol. Cell. Biochem. 315:41-49.
26. Lotan, M., A. Solomon, S. Ben-Bassat, and M. Schwartz. 1994. Cytokines modulate the inflammatory response and change permissiveness to neuronal adhesion in injured mammalian central nervous system. Exp. Neurol. 126: 284-290.
27. McCarthy, K. D., and J. de Vellis. 1980. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J. Cell Biol. 85:890-902.
28. Meeuwsen, S., C. Persoon-Deen, M. Bsibsi, R. Ravid, and J. M. van Noort. 2003. Cytokine, chemokine and growth factor gene profiling of cultured human astrocytes after exposure to proinflammatory stimuli. Glia 43:243-253.
29. Murphy, S. 2000. Production of nitric oxide by glial cells: regulation and potential roles in the CNS. Glia 29:1-13.
30. Okayama, A., K. Mikasa, N. Matsui, N. Higashi, M. Miyamoto, and E. Kita. 2004. An interventional approach to block brain damage caused by Shiga toxin-producing Escherichia coli infection, by use of a combination of phosphodiesterase inhibitors. J. Infect. Dis. 190:2129-2136.
31. O'Neill, L. A., and C. Kaltschmidt. 1997. NF-kappa B: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci. 20:252-258.
32. Pannu, R., A. K. Singh, and I. Singh. 2005. A novel role of lactosylceramide in the regulation of tumor necrosis factor alpha-mediated proliferation of rat primary astrocytes. Implications for astrogliosis following neurotrauma. J. Biol. Chem. 280:13742-13751.
33. Paton, J. C., and A. W. Paton. 1998. Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections. Clin. Microbiol. Rev. 11:450-479.
34. Petruzziello, T. N., I. A. Mawji, M. Khan, and P. A. Marsden. 2009. Verotoxin biology: molecular events in vascular endothelial injury. Kidney Int. Suppl. 2009:S17-S19.
35. Proulx, F., E. G. Seidman, and D. Karpman. 2001. Pathogenesis of Shiga toxin-associated hemolytic uremic syndrome. Pediatr. Res. 50:163-171.
36. Ramegowda, B., J. E. Samuel, and V. L. Tesh. 1999. Interaction of Shiga toxins with human brain microvascular endothelial cells: cytokines as sensitizing agents. J. Infect. Dis. 180:1205-1213.
37. Shiau, M. Y., H. L. Chiou, Y. L. Lee, T. M. Kuo, and Y. H. Chang. 2001. Establishment of a consistent L929 bioassay system for TNF-alpha quantitation to evaluate the effect of lipopolysaccharide, phytomitogens and cyto-differentiation agents on cytotoxicity of TNF-alpha secreted by adherent human mononuclear cells. Mediators Inflamm. 10:199-208.
38. Sommer, C., M. Schafers, M. Marziniak, and K. V. Toyka. 2001. Etanercept reduces hyperalgesia in experimental painful neuropathy. J. Peripher. Nerv. Syst. 6:67-72.
39. Stricklett, P. K., A. K. Hughes, Z. Ergonul, and D. E. Kohan. 2002. Molecular basis for up-regulation by inflammatory cytokines of Shiga toxin 1 cytotoxicity and globotriaosylceramide expression. J. Infect. Dis. 186:976-982.
40. Takuma, K., E. Lee, M. Kidawara, K. Mori, Y. Kimura, A. Baba, and T. Matsuda. 1999. Apoptosis in Ca2+ reperfusion injury of cultured astrocytes: roles of reactive oxygen species and NF-kappaB activation. Eur. J. Neurosci. 11:4204-4212.
41. Tobinick, E. 2008. Perispinal etanercept produces rapid improvement in primary progressive aphasia: identification of a novel, rapidly reversible TNF-mediated pathophysiologic mechanism. Medscape J. Med. 10:135.
42. Tobinick, E. L., and H. Gross. 2008. Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration. J. Neuroin-flammation 5:2.
43. Tobinick, E. L., and H. Gross. 2008. Rapid improvement in verbal fluency and aphasia following perispinal etanercept in Alzheimer's disease. BMC Neurol. 8:27.
44. Utsunomiya, I., J. Ren, K. Taguchi, T. Ariga, T. Tai, Y. Ihara, and T. Miyatake. 2001. Immunohistochemical detection of verotoxin receptors in nervous system. Brain Res. Brain Res. Protoc. 8:99-103.
45. van Setten, P. A., V. W. van Hinsbergh, T. J. van der Velden, N. C. van de Kar, M. Vermeer, J. D. Mahan, K. J. Assmann, L. P. van den Heuvel, and L. A. Monnens. 1997. Effects of TNF alpha on verocytotoxin cytotoxicity in purified human glomerular microvascular endothelial cells. Kidney Int. 51: 1245-1256.
46. Wang, J. Y., A. Y. Shum, C. C. Chao, and J. S. Kuo. 2000. Production of macrophage inflammatory protein-2 following hypoxia/reoxygenation in glial cells. Glia 32:155-164.
47. Yamasaki, Y., Y. Matsuo, J. Zagorski, N. Matsuura, H. Onodera, Y. Itoyama, and K. Kogure. 1997. New therapeutic possibility of blocking cytokine-induced neutrophil chemoattractant on transient ischemic brain damage in rats. Brain Res. 759:103-111.
48. Zoja, C., D. Corna, C. Farina, G. Sacchi, C. Lingwood, M. P. Doyle, V. V. Padhye, M. Abbate, and G. Remuzzi. 1992. Verotoxin glycolipid receptors determine the localization of microangiopathic process in rabbits given verotoxin-1. J. Lab. Clin. Med. 120:229-238.